Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for protein-protein interfaces.
Fig. 1. The sreening workflow of Receptor.AI
The approach involves in-depth molecular simulations of the target protein by itself and in complex with its primary partner proteins, paired with ensemble virtual screening that factors in conformational mobility in both the unbound and complex states. The tentative binding pockets are identified at the protein-protein interaction interface and in distant allosteric areas, aiming to capture the full range of mechanisms of action.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q6PIJ6
UPID:
FBX38_HUMAN
Alternative names:
-
Alternative UPACC:
Q6PIJ6; Q6PK72; Q7Z2U0; Q86VN3; Q9BXY6; Q9H837; Q9HC40
Background:
F-box only protein 38 plays a crucial role in immune regulation by mediating the ubiquitination and proteasomal degradation of PDCD1/PD-1. This process is essential for the regulation of T-cells-mediated immunity and has significant implications for anti-tumor activity. The protein's ability to indirectly stimulate transcription factor KLF7, a key player in neuronal differentiation, further underscores its multifunctional nature.
Therapeutic significance:
Given its pivotal role in modulating T-cell-mediated immunity and its involvement in Neuronopathy, distal hereditary motor, 2D, F-box only protein 38 presents a promising target for therapeutic intervention. Enhancing our understanding of this protein could lead to novel strategies for treating immune-related disorders and certain neurodegenerative diseases.